{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:38:11Z","timestamp":1752230291097,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s13760-020-01530-z","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T06:02:40Z","timestamp":1604296960000},"page":"1065-1067","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuromyelitis optica spectrum disorder complicated with Sj\u00f6gren\u2019s syndrome: first pediatric case responsive to mycophenolate mofetil treatment"],"prefix":"10.1007","volume":"121","author":[{"given":"Gao-Li","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4462-171X","authenticated-orcid":false,"given":"Yin-Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,2]]},"reference":[{"issue":"6","key":"1530_CR1","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3899\/jrheum.151207","volume":"43","author":"JM Kornitzer","year":"2016","unstructured":"Kornitzer JM, Kimura Y, Janow GL (2016) Primary Sjogren syndrome in a child with a neuromyelitis optica spectrum disorder. J Rheumatol 43(6):1260\u20131261. https:\/\/doi.org\/10.3899\/jrheum.151207","journal-title":"J Rheumatol"},{"issue":"1","key":"1530_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R et al (2017) 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76(1):9\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210571","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1530_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189. https:\/\/doi.org\/10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"issue":"7","key":"1530_CR4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/acr.23107","volume":"69","author":"J Birnbaum","year":"2017","unstructured":"Birnbaum J, Atri NM, Baer AN et al (2017) Relationship between neuromyelitis optica spectrum disorder and Sjogren\u2019s syndrome: central nervous system extraglandular disease or unrelated, co-occurring autoimmunity? Arthritis Care Res (Hoboken) 69(7):1069\u20131075. https:\/\/doi.org\/10.1002\/acr.23107","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"1530_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1177\/1352458514540834","volume":"20","author":"J Sawada","year":"2014","unstructured":"Sawada J, Orimoto R, Misu T et al (2014) A case of pathology-proven neuromyelitis optica spectrum disorder with Sjogren syndrome manifesting aphasia and apraxia due to a localized cerebral white matter lesion. Mult Scler 20(10):1413\u20131416. https:\/\/doi.org\/10.1177\/1352458514540834","journal-title":"Mult Scler"},{"issue":"2","key":"1530_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1212\/01.wnl.0000314832.24682.c6","volume":"71","author":"A McKeon","year":"2008","unstructured":"McKeon A, Lennon VA, Lotze T et al (2008) CNS aquaporin-4 autoimmunity in children. Neurology 71(2):93\u2013100. https:\/\/doi.org\/10.1212\/01.wnl.0000314832.24682.c6","journal-title":"Neurology"},{"issue":"4","key":"1530_CR7","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3174\/ajnr.A6003","volume":"40","author":"E Bulut","year":"2019","unstructured":"Bulut E, Karakaya J, Salama S et al (2019) Brain MRI findings in pediatric-onset neuromyelitis optica spectrum disorder: challenges in differentiation from acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 40(4):726\u2013731. https:\/\/doi.org\/10.3174\/ajnr.A6003","journal-title":"AJNR Am J Neuroradiol"},{"key":"1530_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.msard.2018.12.038","volume":"28","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhong X, Shu Y et al (2019) Clinical course, treatment responses and outcomes in Chinese paediatric neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 28:213\u2013220. https:\/\/doi.org\/10.1016\/j.msard.2018.12.038","journal-title":"Mult Scler Relat Disord"},{"key":"1530_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.msard.2018.11.008","volume":"27","author":"S Shahmohammadi","year":"2019","unstructured":"Shahmohammadi S, Doosti R, Shahmohammadi A et al (2019) Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review. Mult Scler Relat Disord 27:350\u2013363. https:\/\/doi.org\/10.1016\/j.msard.2018.11.008","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"1530_CR10","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1212\/NXI.0000000000000046","volume":"1","author":"G Longoni","year":"2014","unstructured":"Longoni G, Banwell B, Filippi M et al (2014) Rituximab as a first-line preventive treatment in pediatric NMOSDs: preliminary results in 5 children. Neurol Neuroimmunol Neuroinflamm 1(4):e46. https:\/\/doi.org\/10.1212\/NXI.0000000000000046","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1530_CR11","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.pediatrneurol.2017.05.015","volume":"73","author":"A Marino","year":"2017","unstructured":"Marino A, Narula S, Lerman MA (2017) First pediatric patient with neuromyelitis optica and Sjogren syndrome successfully treated with tocilizumab. Pediatr Neurol 73:e5\u2013e6. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.05.015","journal-title":"Pediatr Neurol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01530-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-020-01530-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01530-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T22:11:32Z","timestamp":1628374292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-020-01530-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1530"],"URL":"https:\/\/doi.org\/10.1007\/s13760-020-01530-z","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"type":"print","value":"0300-9009"},{"type":"electronic","value":"2240-2993"}],"subject":[],"published":{"date-parts":[[2020,11,2]]},"assertion":[{"value":"2 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}